Some studies have reported decreased CD34+/CD133+/VEGFR2+ cell counts in SSc by flow cytometry [14,15,21], whereas increased circulating EPC levels have been reported elsewhere [13,22,23]. The gene discussed is CD34; the disease is systemic sclerosis.